Concordis Group Incorporated
CNGI · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | – | – | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | – | – | $2 | $2 |
| Revenue | $0 | $0 | $1 | $0 |
| % Growth | -30.3% | -27.1% | 122.4% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 28% | 13.7% | 40.1% | -1.9% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 16.2% | 3.1% | 28.3% | -20.1% |
| Net Income | $0 | -$0 | $0 | -$0 |
| % Margin | 10.5% | -0.9% | 25.4% | -26.6% |
| EPS Diluted | 0.001 | -0 | 0.006 | -0.003 |
| % Growth | 700% | -103.5% | 311.1% | – |
| Operating Cash Flow | $7 | $4 | $5 | $5 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $7 | $4 | $5 | $5 |